Physician profile
Raanan Y Alter
NPI 1558789826
$128,167.81
in general payments reported to CMS, 2019-2025
7 companies · $36K in 2025
The $36K reported for 2025 was more than what 96% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.11 · 2021: $387 · 2022: $6,231 · 2023: $37K · 2024: $49K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $88K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $11K · Food and Beverage: $8,722 · Gift: $23.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $88,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,000.00 |
| Travel and Lodging | $10,749.89 |
| Food and Beverage | $8,721.93 |
| Gift | $23.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $127,079.13 | 2019-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals Lp | $362.16 | 2021 | |
| Baxter Healthcare | $343.64 | 2021-2025 | Floseal, Perclot |
| Coopersurgical, INC. | $125.04 | 2023-2024 | Advincula Delineator Uterine Manipulator |
| On Target Laboratories, INC | $97.42 | 2025 | Cytalux |
| Conmed Corporation | $82.34 | 2023-2025 | Airseal |
| Myriad Genetic Laboratories, INC. | $78.08 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raanan Alter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.